Atlas Trials

Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.

Clinical trial NCT04354129 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04354129
Sponsor
University of Alberta
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Primary Immune Deficiency DisorderSecondary Immune Deficiency
Start date
2023-04-01
Primary completion
2026-07-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.